Clinical Trial Update: A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103) [Phase 1]

View source ↗

Summary

This is a Phase 1 trial evaluating Anvumetostat in combination with other therapies for advanced gastrointestinal, biliary tract, or pancreatic cancers with hom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Gastrointestinal Cancer
• Pancreatic Cancer

Drugs mentioned

• Anvumetostat (Anvumetostat)

Snippet

Sponsor: Amgen | Conditions: Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers | Phase 1 | Status: RECRUITING